Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs ; volume:21 ; number:1 ; day:17 ; month:9 ; year:2021 ; pages:1-27 ; date:12.2021
Cancer cell international ; 21, Heft 1 (17.9.2021), 1-27, 12.2021
- Creator
-
Olatunde, Ahmed
Nigam, Manisha
Singh, Rahul Kunwar
Panwar, Abhaya Shikhar
Lasisi, Abdulwahab
Alhumaydhi, Fahad A.
Jyoti kumar, Vijay
Mishra, Abhay Prakash
Sharifi-Rad, Javad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-021-02202-5
- URN
-
urn:nbn:de:101:1-2021112720201475184517
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Olatunde, Ahmed
- Nigam, Manisha
- Singh, Rahul Kunwar
- Panwar, Abhaya Shikhar
- Lasisi, Abdulwahab
- Alhumaydhi, Fahad A.
- Jyoti kumar, Vijay
- Mishra, Abhay Prakash
- Sharifi-Rad, Javad
- SpringerLink (Online service)
Other Objects (12)
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions
Evolutionary repurposing of cAMP and PKA signaling pathways in kinetoplastids
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses
Drug repurposing
Challenges and Opportunities for Celecoxib Repurposing
Understanding and repurposing CRISPR-mediated alternative splicing
Metformin, the remarkable and unique antidiabetic agent
Actions and reactions
Identifying patterns to uncover the importance of biological pathways on known drug repurposing scenarios
Repurposing of promoters and enhancers during mammalian evolution
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions
Evolutionary repurposing of cAMP and PKA signaling pathways in kinetoplastids
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses
Drug repurposing
Challenges and Opportunities for Celecoxib Repurposing
Understanding and repurposing CRISPR-mediated alternative splicing
Metformin, the remarkable and unique antidiabetic agent
Actions and reactions
Identifying patterns to uncover the importance of biological pathways on known drug repurposing scenarios
Repurposing of promoters and enhancers during mammalian evolution
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions
Evolutionary repurposing of cAMP and PKA signaling pathways in kinetoplastids
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses
Drug repurposing
Challenges and Opportunities for Celecoxib Repurposing
Understanding and repurposing CRISPR-mediated alternative splicing
Metformin, the remarkable and unique antidiabetic agent
Actions and reactions
Identifying patterns to uncover the importance of biological pathways on known drug repurposing scenarios